open access

Vol 2, No 1 (2017)
ORIGINAL PAPERS
Published online: 2017-03-22
Get Citation

Outcomes of vitrectomy in severe complications of proliferative diabetic retinopathy

Dorota Borowicz, Dominika Nowakowska, Edyta Koman, Katarzyna Nowomiejska, Robert Rejdak
DOI: 10.5603/OJ.2017.0005
·
Ophthalmology J 2017;2(1):17-21.

open access

Vol 2, No 1 (2017)
ORIGINAL PAPERS
Published online: 2017-03-22

Abstract

INTRODUCTION. The aim of our study is to describe the anatomical and functional results of pars plana vitrectomy (PPV) among diabetic patients treated due to tractional retinal detachment (TRD) or non-clearing vitreous haemorrhage (VH).

MATERIALS AND METHODS. A retrospective analysis was made of clinical data of 45 eyes treated with 23G PPV for TRD (17 eyes) or VH (28 eyes). Preoperative and final visual outcomes and postoperative complications were recorded. The mean follow-up period was 12 months.

RESULTS. The postoperative visual acuity (VA) improved significantly in 60% of eyes, but remained unchanged or was worse in 40%. Improvement of VA was more pronounced in the VH group. PPV was performed with silicone oil tamponade in 66.5%, air tamponade in 29%, and gas tamponade in 4.5%. Postoperative complications included: retinal re-detachment (seven eyes), secondary glaucoma (nine eyes), and recurrent VH (two eyes).

CONCLUSIONS. PPV is an effective treatment method of complications of severe proliferative diabetic retinopathy inter alia the TRD and VH. Because surgical management of TRD and VH is demanding, anatomical and functional results are limited by complications.  

Abstract

INTRODUCTION. The aim of our study is to describe the anatomical and functional results of pars plana vitrectomy (PPV) among diabetic patients treated due to tractional retinal detachment (TRD) or non-clearing vitreous haemorrhage (VH).

MATERIALS AND METHODS. A retrospective analysis was made of clinical data of 45 eyes treated with 23G PPV for TRD (17 eyes) or VH (28 eyes). Preoperative and final visual outcomes and postoperative complications were recorded. The mean follow-up period was 12 months.

RESULTS. The postoperative visual acuity (VA) improved significantly in 60% of eyes, but remained unchanged or was worse in 40%. Improvement of VA was more pronounced in the VH group. PPV was performed with silicone oil tamponade in 66.5%, air tamponade in 29%, and gas tamponade in 4.5%. Postoperative complications included: retinal re-detachment (seven eyes), secondary glaucoma (nine eyes), and recurrent VH (two eyes).

CONCLUSIONS. PPV is an effective treatment method of complications of severe proliferative diabetic retinopathy inter alia the TRD and VH. Because surgical management of TRD and VH is demanding, anatomical and functional results are limited by complications.  

Get Citation

Keywords

proliferative diabetic retinopathy, vitreous haemorrhage, tractional retinal detachment, vitrectomy

About this article
Title

Outcomes of vitrectomy in severe complications of proliferative diabetic retinopathy

Journal

Ophthalmology Journal

Issue

Vol 2, No 1 (2017)

Pages

17-21

Published online

2017-03-22

DOI

10.5603/OJ.2017.0005

Bibliographic record

Ophthalmology J 2017;2(1):17-21.

Keywords

proliferative diabetic retinopathy
vitreous haemorrhage
tractional retinal detachment
vitrectomy

Authors

Dorota Borowicz
Dominika Nowakowska
Edyta Koman
Katarzyna Nowomiejska
Robert Rejdak

References (10)
  1. Ho T, Smiddy WE, Flynn HW. Vitrectomy in the management of diabetic eye disease. Surv Ophthalmol. 1992; 37(3): 190–202.
  2. Machemer R, Buettner H, Parel JM, et al. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol. 1971; 75(4): 813–820.
  3. O'Malley C, Heintz RM. Vitrectomy via the pars plana--a new instrument system. Trans Pac Coast Otoophthalmol Soc Annu Meet. 1972; 53: 121–137.
  4. Heimann K, Dahl B, Dimopoulos S, et al. Pars plana vitrectomy and silicone oil injection in proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1989; 227(2): 152–156.
  5. Newman DK. Surgical management of the late complications of proliferative diabetic retinopathy. Eye (Lond). 2010; 24(3): 441–449.
  6. Oshima Y, Shima C, Wakabayashi T, et al. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology. 2009; 116(5): 927–938.
  7. Dikopf MS, Patel KH, Setlur VJ, et al. Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment. Eye (Lond). 2015; 29(9): 1213–1219.
  8. Sharma T, Fong A, Lai TY, et al. Surgical treatment for diabetic vitreoretinal diseases: a review. Clin Exp Ophthalmol. 2016; 44(4): 340–354.
  9. Abunajma MA, Al-Dhibi H, Abboud EB, et al. The outcomes and prognostic factors of vitrectomy in chronic diabetic traction macular detachment. Clin Ophthalmol. 2016; 10: 1653–1661.
  10. Sternfeld A, Axer-Siegel R, Stiebel-Kalish H, et al. Advantages of diabetic tractional retinal detachment repair. Clin Ophthalmol. 2015; 9: 1989–1994.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl